About US
Contact us
-
China allows trial of investigators of GSK sex-tape scandal to go publicTwo weeks after raising international concerns by vowing to prosecute private investigator Peter Humphrey and his wife Yu Yingzeng in a closed trial, China has abruptly changed course. Now Humphrey an2014/7/18
-
Novartis sales flag on Diovan generics, but CEO promises cost cuts will fuel profitsTake a look at Novartis' ($NVS) second-quarter results for reasons why it engineered that big asset swap-and-sale with GlaxoSmithKline ($GSK) and Eli Lilly ($LLY). The two units Novartis is unloading,2014/7/17
-
Health Canada approves Sunovion’s Aptiom to treat partial-onset seizures in epilepsy patientsHealth Canada has approved Sunovion Pharmaceuticals Canada's Aptiom, a voltage-gated sodium channel inhibitor, for use as a once-daily adjunctive therapy for treatment of partial-onset seizures in pat2014/7/16
-
Mylan to acquire non-US developed markets specialty and assets from AbbottMylan has entered into a definitive agreement to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction of $5.3bn. Under the agreement, Abbott w2014/7/16
-
Zafgen’s Prader-Willi syndrome therapy receives orphan drug designation in EuropeThe European Commission (EC) has granted orphan drug designation to US-based Zafgen for its beloranib for treating Prader-Willi syndrome. Beloranib is a potent inhibitor of Methionine aminopeptidase-2014/7/15
-
Baxter announces acquisition of AesRxBaxter International has announced the acquisition of US biopharmaceutical company AesRx, including development and commercialisation of AesRx's investigational sickle cell disease treatment Aes-103.2014/7/15
-
FDA accepts Kythera’s ATX-101 new drug applicationKythera Biopharmaceuticals' new drug application (NDA) for its ATX-101, a submental contouring injectable drug, has been accepted for filing by the US Food and Drug Administration (FDA). According to2014/7/14
-
Iroko files new drug application for Zorvolex in LebanonUS-based Iroko Pharmaceuticals has announced the filing of a new drug application for Zorvolex, a nonsteroidal anti-inflammatory drug, with the Republic of Lebanon Ministry of Public Health (MOPH) for2014/7/14
-
Letrozole boosts fertility in women with PCOS, says studyPenn State College of Medicine's nationwide study has shown that Letrozole resulted in higher birth rates in women with polycystic ovary syndrome (PCOS) than the current preferred infertility treatmen2014/7/11
-
Bayer receives Canadian approval for Nexavar to treat differentiated thyroid cancerHealth Canada has approved Bayer's Nexavar (sorafenib tablets) for treatment of patients with locally advanced or metastatic, progressive, differentiated (papillary/follicular/Hurthle cell) thyroid ca2014/7/11